Data / Form D filings / Edgemont Pharmaceuticals, LLC
Edgemont Pharmaceuticals, LLC: Form D filings
Edgemont Pharmaceuticals, LLC, a pharmaceuticals company in Mendham, NJ, filed 3 Form D notices with the SEC in 2010. The latest, on December 9, 2010, reports $4.8 million sold of a $5 million offering to 32 investors.
Find out what Edgemont Pharmaceuticals, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 88 EAST MAIN STREET, SUITE 506, Mendham, NJ, 07945
- Phone
- (973) 543-2474
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- New Jersey
- Year incorporated
- 2006
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1488709
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 9, 2010 | Amendment | $5,000,000 | $4,845,795 | $154,205 | 32 | Mar 22, 2010 | sec.gov |
| Apr 7, 2010 | Amendment | $3,500,000 | $1,310,000 | $2,190,000 | 11 | Mar 22, 2010 | sec.gov |
| Apr 6, 2010 | New notice | $3,500,000 | $1,310,000 | $2,190,000 | 11 | Mar 22, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Timothy A. McInerney | Director | |
| Barbara A. Duncan | Director | |
| Robert A. Zerbe | Director | |
| Douglas A. Saltel | Executive Officer, Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Dec 6, 2010 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Edgemont Pharmaceuticals, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.